How old fat cells trigger inflammation and raise risks
Researchers using cohort studies and a mouse model found that how old fat cells behave matters: senescent adipose tissue releases ANGPTL8, a circulating factor tied to age-related disease and mortality in people and mice. Higher blood levels tracked with older biological-age estimates and higher 10-year death risk.
According to reporting from Lifespan Research Institute, aging fat is not only storage tissue. It acts as an endocrine organ whose senescence-associated secretory phenotype (SASP) can fuel systemic “inflammaging.” For more longevity science coverage, see our Longevity & Biohacking hub.
Key Takeaways
- How old fat cells secrete ANGPTL8 links circulating levels to biological age and mortality signals in large human cohorts.
- About 250 ng/L serum ANGPTL8 aligned with the lowest biological-age estimates; much higher levels tracked with older estimates.
- Mice lacking Angptl8 showed less fat senescence, better physical performance, and longer lifespan than wild-type peers.
- ANGPTL8 appears to act through AKT2 and the AKT/mTOR/S6K pathway; human clearance therapies were not tested.
What did the human cohort clocks show?
Researchers built MBA8-Clock with data from the China Cardiometabolic Disease and Cancer Cohort of nearly 10,000 people. A multilayer perceptron framework estimated age with roughly a five-year error and treated ANGPTL8 as a core metabolic marker.
Circulating ANGPTL8 near 250 nanograms per liter of serum associated with the lowest biological-age estimates. Levels several times higher, especially fourfold or more, pointed to markedly older estimates. Dropping ANGPTL8 from the clock weakened its predictive power.
A separate AIMR-Model, tuned with an extreme gradient framework on 10-year all-cause mortality, again flagged ANGPTL8. People with higher levels were significantly more likely to have died within a decade. Analysts said the factor may amplify age-related clinical vulnerability alongside risks such as high blood pressure, not only act as an isolated marker.
Why do aging fat tissues matter for inflammation?
The paper frames adipose aging as a driver of broader aging biology. Senescent fat can emit enough SASP to stimulate systemic inflammation, shifting metabolism toward dysregulation rather than merely reflecting it.
ANGPTL8 is a metabolic regulator that rises when insulin is given. Earlier work linked higher circulating levels to diabetic kidney disease, diabetic atherosclerosis, secondary heart-attack risk in cardiovascular patients, and all-cause mortality in diabetic patients. The new analysis positions senescent fat as a major source of the circulating protein.
What happened when mice lacked Angptl8?
In mice, ANGPTL8 rose with age: 22-month-old animals had more than 4-month-olds, mainly from adipose tissue rather than systemic liver output. Animals engineered without Angptl8 aged better than wild-type controls.
Old knockout mice had less fat mass, less senescence in fat, and lower circulating SASP factors. They lasted longer on rotarod and treadmill tests, explored more, kept more gastrocnemius mass and fast-twitch fibers, and lived longer overall.
Mechanistically, ANGPTL8 bound AKT2 and engaged the AKT/mTOR/S6K pathway. Knockouts showed lower AKT, mTOR, and S6K activity; cell work indicated AKT is required for ANGPTL8’s push toward senescence. Authors call ANGPTL8 both a biomarker and a functional aging effector, but they did not test drugs that clear it from wild-type bloodstreams. Any human benefit would still need clinical proof.